IL-6 Inhibitors, Frailty and Polymyalgia Rheumatica

RheumNow

S. Sattui

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

PMR Mimics: PMR vs RA?

RheumNow

R. Spiera

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

Update in Rheumatology 2023 (Gout, JAK safety in RA, Dermatomyositis…

John Tesser

2023 Rheumatology Year in Review

RheumNow

J. Cush

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

Resolution of PMR Signs and Symptoms in Patients Treated with Sarilu…

Robert Spiera

Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…

Cleveland Clinic Rheumatology

L. Calabrese

PMR: Must Rule Outs

RheumNow

L. Calabrese

PMR - Diagnosis & Monitoring

RheumNow

A. Dua, J. Cush, C. Owen, S. Paget

Diagnosing Polymyalgia Rheumatica: What is the Role of Imaging? Whic…

Hospital for Special Surgery

R. Spiera

EULAR Daily Recap: Day 4

RheumNow

D. Liew, A. Najm, J. Cush

Polymyalgia Rheumatica Therapy: Is Tocilizumab Effective, Safe and W…

Hospital for Special Surgery

R. Spiera

Checkpoint Inhibitors and Rheumatic Disease

NYU Langone

A. Bass

COVID-19 in Rheumatology: Where We Are Now

Keck School of Medicine of USC

B. Ngo

ACR Convergence 2023 Highlights: Abstract Recap Panel - Wednesday

RheumNow

J. Pope, R. Conway, M. Ramahi, J. Cush

PMR/GCA Panel EULAR 2022

RheumNow

R. Conway, S. Mackie, M. Putman

EULAR® 2024 Insights: Ultrasound of Peripheral Arteries in GCA

EULAR® 2024 Insights

W. Schmidt

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…

Cleveland Clinic Rheumatology

C. Calabrese